CUCINELLA, LAURA
 Distribuzione geografica
Continente #
AS - Asia 1.037
NA - Nord America 1.003
EU - Europa 630
SA - Sud America 180
AF - Africa 58
OC - Oceania 3
Totale 2.911
Nazione #
US - Stati Uniti d'America 950
CN - Cina 291
SG - Singapore 274
VN - Vietnam 189
HK - Hong Kong 147
BR - Brasile 138
IE - Irlanda 111
RU - Federazione Russa 108
IT - Italia 104
DE - Germania 70
FR - Francia 56
FI - Finlandia 50
GB - Regno Unito 48
IN - India 40
ZA - Sudafrica 36
CA - Canada 28
MX - Messico 22
SE - Svezia 18
AR - Argentina 17
BD - Bangladesh 14
IQ - Iraq 11
ID - Indonesia 9
NL - Olanda 9
PL - Polonia 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
ES - Italia 7
CL - Cile 6
PH - Filippine 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
JP - Giappone 5
MA - Marocco 5
TR - Turchia 5
UZ - Uzbekistan 5
AT - Austria 4
CO - Colombia 4
EG - Egitto 4
PK - Pakistan 4
DK - Danimarca 3
HR - Croazia 3
JO - Giordania 3
MY - Malesia 3
PE - Perù 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NG - Nigeria 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MG - Madagascar 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
VC - Saint Vincent e Grenadine 1
Totale 2.911
Città #
Singapore 150
Hong Kong 143
San Jose 123
Ashburn 111
Dublin 110
Beijing 93
Chandler 85
Dallas 83
Ho Chi Minh City 54
Hanoi 44
Munich 43
Lauterbourg 42
Johannesburg 35
New York 35
Los Angeles 34
Milan 28
Turku 23
Moscow 22
Boardman 21
Helsinki 21
Redondo Beach 21
Montreal 18
Nanjing 17
Stockholm 17
Shanghai 16
Brooklyn 15
São Paulo 14
Buffalo 13
Lawrence 13
Princeton 13
Medford 12
Orem 12
Poplar 12
Chicago 11
Changsha 10
Da Nang 10
Santa Clara 10
Chennai 9
Denver 9
Rome 9
Haiphong 8
Houston 8
Jacksonville 8
Nanchang 8
San Francisco 8
Warsaw 8
Hebei 7
Wilmington 7
Mexico City 6
Shenyang 6
Atlanta 5
Baku 5
Biên Hòa 5
Buenos Aires 5
Falkenstein 5
Frankfurt am Main 5
Jiaxing 5
Rio de Janeiro 5
Seattle 5
Shenzhen 5
Tashkent 5
Thái Nguyên 5
Tokyo 5
Amsterdam 4
Austin 4
Baghdad 4
Boston 4
City of London 4
Hyderabad 4
Jakarta 4
London 4
Menlo Park 4
Nha Trang 4
Ninh Bình 4
Nuremberg 4
Piracicaba 4
Prague 4
Quezon City 4
Recife 4
Toronto 4
Bardolino 3
Bismarck 3
Bogotá 3
Bologna 3
Brasília 3
Bến Tre 3
Cairo 3
Campinas 3
Casablanca 3
Concord 3
Contagem 3
Council Bluffs 3
Fairfield 3
Go Vap 3
Guayaquil 3
Hangzhou 3
Manchester 3
Mumbai 3
New Delhi 3
Palermo 3
Totale 1.828
Nome #
Advances in pharmacotherapy for treating female sexual dysfunction 200
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 129
Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL) 114
Medical Treatment of Female Sexual Dysfunction 108
Sexuality in premature ovarian insufficiency 102
Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of premature ovarian insufficiency 102
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 96
Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics? 96
Efficacy and safety of a device that combines multipolar radiofrequency with pulsed electromagnetic field for the treatment of vulvovaginal atrophy: a randomized, sham-controlled trial 93
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 93
Different local estrogen therapies for a tailored approach to GSM 85
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 83
The role of hormone therapy in urogenital health after menopause 83
Body Image and Other Mood Vulnerabilities in Adolescents with Polycystic Ovary Syndrome and Metabolic Alterations 77
Menopause and female sexual dysfunctions (FSDs) 73
Relationship between personality traits and sexual function in symptomatic postmenopausal women 69
Impact of Obesity on Pubertal Timing and Male Fertility 69
Epidemiological transitions in a life-course perspective: challenges and opportunities for healthy ageing 67
Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens – Cluster analysis of a web-based Italian survey among women over 40 64
Sexuality, pelvic floor/vaginal health and contraception at menopause 62
Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype 61
Menopause and endometriosis 60
Insights into the vulvar component of the genitourinary syndrome of menopause (GSM) 58
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy 56
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause 54
Gene-environment interaction in functional hypothalamic amenorrhea 51
A forward-looking approach in women living with the Fontan circulation: from cardio-obstetric to cardio-reproductive medicine 50
Women’s attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample 48
Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine? 47
Impact of climate and environmental change on the menopause 47
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms 45
Loss of pubic hair in women over 40 years: prevalence and association with osteoporotis risk 44
Sexual health and contraception in the menopause journey 43
Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of premature ovarian insufficiency 41
Obesity and sexual health: focus on postmenopausal women 41
Sexual function and distress in postmenopausal women with medication overuse headache (MOH) 39
A preliminary analysis of the relationship between follicle-stimulating hormone and metabolic parameters in postmenopausal women 35
Menopause and Sexual Health: Hormones, Aging or Both? 33
The Use of Nigella sativa in Cardiometabolic Diseases 33
Thyroid diseases and female sexual dysfunctions 30
Bringing sex back into the relationship in midlife couples 28
Signs and symptoms of vulvovaginal atrophy (VVA) in clinical practice–the possible involvement of thyroid autoimmunity in genitourinary syndrome of menopause (GSM) 26
Menopause and Sexual Health: Hormones, Aging or Both? 23
From pregnancy to menopause: impact of reproductive history on women health at midlife 22
Genitourinary syndrome of menopause: Should we treat symptoms or signs? 20
“My little secret”, a website for sexual health of postmenopausal women 20
Personality traits and attitudes towards the frequency of menstrual/withdrawal bleeding: a survey in a clinical sample of Italian women 20
Reproductive History and Cardio-Metabolic Risk in the Postmenopausal Age 19
Timely diagnosis is vital: The effect of delayed diagnosis on bone mineral density in women with premature ovarian insufficiency 15
Totale 2.974
Categoria #
all - tutte 10.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 0 1
2021/202249 0 1 0 0 0 0 0 4 2 1 14 27
2022/2023273 22 25 0 8 27 22 0 16 128 0 18 7
2023/2024118 12 23 2 10 6 23 9 3 4 3 5 18
2024/2025619 25 22 3 8 2 58 33 67 144 31 89 137
2025/20261.782 136 159 116 175 332 113 329 119 179 124 0 0
Totale 2.974